{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T20:23:44Z","timestamp":1791318224271,"version":"4.3.1"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.bcp.2019.113715","type":"journal-article","created":{"date-parts":[[2019,11,18]],"date-time":"2019-11-18T11:16:56Z","timestamp":1574075816000},"page":"113715","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":69,"special_numbering":"C","title":["Catalpol suppresses osteoclastogenesis and attenuates osteoclast-derived bone resorption by modulating PTEN activity"],"prefix":"10.1016","volume":"171","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9091-1745","authenticated-orcid":false,"given":"Jiahong","family":"Meng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenkan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenhe","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangyao","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianqiao","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigui","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiqi","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6937","key":"10.1016\/j.bcp.2019.113715_b0005","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature01658","article-title":"Osteoclast differentiation and activation","volume":"423","author":"Boyle","year":"2003","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.bcp.2019.113715_b0010","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/S1359-6446(04)03265-9","article-title":"Osteolytic bone diseases: physiological analogues of bone resorption effectors as alternative therapeutic tools","volume":"10","author":"Heymann","year":"2005","journal-title":"Drug Discov. Today"},{"issue":"3","key":"10.1016\/j.bcp.2019.113715_b0015","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s00296-010-1586-z","article-title":"new and future treatments of osteoporosis","volume":"31","author":"Salari Sharif","year":"2011","journal-title":"Rheumatol. Int."},{"issue":"2","key":"10.1016\/j.bcp.2019.113715_b0020","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.bone.2006.09.023","article-title":"The molecular understanding of osteoclast differentiation","volume":"40","author":"Asagiri","year":"2007","journal-title":"Bone"},{"issue":"6","key":"10.1016\/j.bcp.2019.113715_b0025","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1080\/15216540500137669","article-title":"RANKing intracellular signaling in osteoclasts","volume":"57","author":"Feng","year":"2005","journal-title":"IUBMB Life"},{"issue":"4","key":"10.1016\/j.bcp.2019.113715_b0030","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1038\/sj.emboj.7600564","article-title":"RANK-mediated amplification of TRAF6 signaling leads to NFATc1 induction during osteoclastogenesis","volume":"24","author":"Gohda","year":"2005","journal-title":"EMBO J."},{"issue":"4","key":"10.1016\/j.bcp.2019.113715_b0035","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2302\/kjm.60.101","article-title":"Regulators of osteoclast differentiation and cell-cell fusion","volume":"60","author":"Miyamoto","year":"2011","journal-title":"Keio J. Med."},{"issue":"23","key":"10.1016\/j.bcp.2019.113715_b0040","doi-asserted-by":"crossref","first-page":"20603","DOI":"10.1074\/jbc.M212093200","article-title":"Involvement of upstream stimulatory factors 1 and 2 in RANKL-induced transcription of tartrate-resistant acid phosphatase gene during osteoclast differentiation","volume":"278","author":"Liu","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2019.113715_b0045","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.jep.2017.01.021","article-title":"Rehmanniae Radix in osteoporosis: A review of traditional Chinese medicinal uses, phytochemistry, pharmacokinetics and pharmacology","volume":"198","author":"Liu","year":"2017","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.bcp.2019.113715_b0050","article-title":"Traditional Chinese Medicine formulas for the treatment of osteoporosis: Implication for antiosteoporotic drug discovery","author":"Zhang","year":"2016","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.bcp.2019.113715_b0055","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13020-016-0096-7","article-title":"Antidiabetic and antioxidant effects of catalpol extracted from Rehmannia glutinosa (Di Huang) on rat diabetes induced by streptozotocin and high-fat, high-sugar feed","volume":"11","author":"Zhu","year":"2016","journal-title":"Chin. Med."},{"key":"10.1016\/j.bcp.2019.113715_b0060","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.phrs.2017.12.026","article-title":"Catalpol ameliorates hepatic insulin resistance in type 2 diabetes through acting on AMPK\/NOX4\/PI3K\/AKT pathway","volume":"130","author":"Yan","year":"2018","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bcp.2019.113715_b0065","doi-asserted-by":"crossref","DOI":"10.1007\/s11418-016-0988-y","article-title":"Catalpol reduces the production of inflammatory mediators via PPAR-gamma activation in human intestinal Caco-2 cells","author":"Park","year":"2016","journal-title":"J. Nat. Med."},{"issue":"3","key":"10.1016\/j.bcp.2019.113715_b0070","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1007\/s12013-014-0355-0","article-title":"Catalpol inhibited the proliferation of T24 human bladder cancer cells by inducing apoptosis through the blockade of Akt-mediated anti-apoptotic signaling","volume":"71","author":"Jin","year":"2015","journal-title":"Cell Biochem. Biophys."},{"issue":"2","key":"10.1016\/j.bcp.2019.113715_b0075","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.intimp.2014.07.011","article-title":"Protective effect of catalpol on lipopolysaccharide-induced acute lung injury in mice","volume":"23","author":"Fu","year":"2014","journal-title":"Int. Immunopharmacol."},{"issue":"2","key":"10.1016\/j.bcp.2019.113715_b0080","doi-asserted-by":"crossref","first-page":"111","DOI":"10.4149\/gpb-2018044","article-title":"Catalpol attenuates lipopolysaccharide-induced inflammatory responses in BV2 microglia through inhibiting the TLR4-mediated NF-kappaB pathway","volume":"38","author":"Choi","year":"2019","journal-title":"Gen. Physiol. Biophys."},{"issue":"3","key":"10.1016\/j.bcp.2019.113715_b0085","doi-asserted-by":"crossref","first-page":"3741","DOI":"10.3892\/ol.2017.6580","article-title":"Catalpol promotes cellular apoptosis in human HCT116 colorectal cancer cells via microRNA-200 and the downregulation of PI3K-Akt signaling pathway","volume":"14","author":"Liu","year":"2017","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.bcp.2019.113715_b0090","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/978-1-62703-481-4_3","article-title":"Isolation, culture, and functional evaluation of bone marrow-derived macrophages","volume":"1031","author":"Davis","year":"2013","journal-title":"Methods Mol. Biol."},{"issue":"1","key":"10.1016\/j.bcp.2019.113715_b0095","doi-asserted-by":"crossref","DOI":"10.1186\/s13287-019-1143-y","article-title":"Catalpol promotes the osteogenic differentiation of bone marrow mesenchymal stem cells via the Wnt\/\u03b2-catenin pathway","volume":"10","author":"Zhu","year":"2019","journal-title":"Stem Cell Res. Ther."},{"issue":"7","key":"10.1016\/j.bcp.2019.113715_b0100","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1002\/jbmr.141","article-title":"Guidelines for assessment of bone microstructure in rodents using micro-computed tomography","volume":"25","author":"Bouxsein","year":"2010","journal-title":"J. Bone Mineral Res."},{"issue":"1","key":"10.1016\/j.bcp.2019.113715_b0105","first-page":"114","article-title":"The roles of protein tyrosine phosphatases in bone-resorbing osteoclasts, Biochimica et biophysica acta","volume":"1866","author":"Shalev","year":"2019","journal-title":"Mol. Cell Res."},{"issue":"7","key":"10.1016\/j.bcp.2019.113715_b0110","doi-asserted-by":"crossref","first-page":"5001","DOI":"10.1074\/jbc.M209299200","article-title":"PTEN regulates RANKL- and osteopontin-stimulated signal transduction during osteoclast differentiation and cell motility","volume":"278","author":"Sugatani","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.bcp.2019.113715_b0115","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.bone.2013.02.005","article-title":"PTEN regulation by the Akt\/GSK-3beta axis during RANKL signaling","volume":"55","author":"Jang","year":"2013","journal-title":"Bone"},{"issue":"1","key":"10.1016\/j.bcp.2019.113715_b0120","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1042\/BST20150224","article-title":"The PTEN protein: cellular localization and post-translational regulation","volume":"44","author":"Leslie","year":"2016","journal-title":"Biochem. Soc. Trans."},{"issue":"5484","key":"10.1016\/j.bcp.2019.113715_b0125","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1126\/science.289.5484.1508","article-title":"Therapeutic approaches to bone diseases","volume":"289","author":"Rodan","year":"2000","journal-title":"Science"},{"issue":"12","key":"10.1016\/j.bcp.2019.113715_b0130","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.1185\/030079907X242890","article-title":"The impact of osteoporosis medication beliefs and side-effect experiences on non-adherence to oral bisphosphonates","volume":"23","author":"McHorney","year":"2007","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.bcp.2019.113715_b0135","doi-asserted-by":"crossref","first-page":"234","DOI":"10.3389\/fmed.2017.00234","article-title":"Key triggers of osteoclast-related diseases and available strategies for targeted therapies: a review","volume":"4","author":"Bi","year":"2017","journal-title":"Front. Med."},{"issue":"3","key":"10.1016\/j.bcp.2019.113715_b0140","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1021\/acs.jnatprod.5b01055","article-title":"Natural products as sources of new drugs from 1981 to 2014","volume":"79","author":"Newman","year":"2016","journal-title":"J. Nat. Prod."},{"issue":"2","key":"10.1016\/j.bcp.2019.113715_b0145","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0092-8674(00)81569-X","article-title":"Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation","volume":"93","author":"Lacey","year":"1998","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.bcp.2019.113715_b0150","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1128\/MCB.22.4.992-1000.2002","article-title":"Receptor activator of NF-kappaB ligand (RANKL) activates TAK1 mitogen-activated protein kinase kinase kinase through a signaling complex containing RANK, TAB2, and TRAF6","volume":"22","author":"Mizukami","year":"2002","journal-title":"Mol. Cell. Biol."},{"issue":"25","key":"10.1016\/j.bcp.2019.113715_b0155","doi-asserted-by":"crossref","first-page":"18245","DOI":"10.1074\/jbc.M610701200","article-title":"NF-kappaB p50 and p52 regulate receptor activator of NF-kappaB ligand (RANKL) and tumor necrosis factor-induced osteoclast precursor differentiation by activating c-Fos and NFATc1","volume":"282","author":"Yamashita","year":"2007","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.bcp.2019.113715_b0160","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1359\/jbmr.2002.17.2.192","article-title":"In vivo RANK signaling blockade using the receptor activator of NF-kappaB: Fc effectively prevents and ameliorates wear debris-induced osteolysis via osteoclast depletion without inhibiting osteogenesis","volume":"17","author":"Childs","year":"2002","journal-title":"J. Bone Mineral Res."},{"issue":"1","key":"10.1016\/j.bcp.2019.113715_b0165","doi-asserted-by":"crossref","first-page":"163","DOI":"10.4049\/jimmunol.1101254","article-title":"Akt induces osteoclast differentiation through regulating the GSK3beta\/NFATc1 signaling cascade","volume":"188","author":"Moon","year":"2012","journal-title":"J. Immunol."},{"issue":"Pt 13","key":"10.1016\/j.bcp.2019.113715_b0170","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1242\/jcs.114.13.2375","article-title":"Tumor suppressor PTEN: modulator of cell signaling, growth, migration and apoptosis","volume":"114","author":"Yamada","year":"2001","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.bcp.2019.113715_b0175","doi-asserted-by":"crossref","DOI":"10.1096\/fj.201800109R","article-title":"The Mfge8-alpha8beta1-PTEN pathway regulates airway smooth muscle contraction in allergic inflammation","author":"Khalifeh-Soltani","year":"2018","journal-title":"FASEB J."},{"issue":"15","key":"10.1016\/j.bcp.2019.113715_b0180","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1096\/fj.02-1107fje","article-title":"Abnormal PTEN expression in portal hypertensive gastric mucosa: a key to impaired PI 3-kinase\/Akt activation and delayed injury healing?","volume":"17","author":"Tsugawa","year":"2003","journal-title":"FASEB J."},{"issue":"8","key":"10.1016\/j.bcp.2019.113715_b0185","doi-asserted-by":"crossref","first-page":"4240","DOI":"10.1073\/pnas.96.8.4240","article-title":"New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase\/AKT pathway","volume":"96","author":"Cantley","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"7","key":"10.1016\/j.bcp.2019.113715_b0190","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1042\/BJ20150624","article-title":"Profilin-PTEN interaction suppresses NF-kappaB activation via inhibition of IKK phosphorylation","volume":"473","author":"Zaidi","year":"2016","journal-title":"Biochem. J."},{"issue":"1","key":"10.1016\/j.bcp.2019.113715_b0195","doi-asserted-by":"crossref","DOI":"10.1111\/acel.12858","article-title":"Loss of PTEN induces lung fibrosis via alveolar epithelial cell senescence depending on NF-kappaB activation","volume":"18","author":"Tian","year":"2019","journal-title":"Aging Cell"},{"issue":"1","key":"10.1016\/j.bcp.2019.113715_b0200","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1136\/annrheumdis-2013-203486","article-title":"Loss of phosphatase and tensin homolog (PTEN) in myeloid cells controls inflammatory bone destruction by regulating the osteoclastogenic potential of myeloid cells","volume":"74","author":"Bluml","year":"2015","journal-title":"Ann. Rheum. Dis."},{"issue":"2","key":"10.1016\/j.bcp.2019.113715_b0205","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1074\/jbc.M009134200","article-title":"The tumor suppressor PTEN is phosphorylated by the protein kinase CK2 at its C terminus. Implications for PTEN stability to proteasome-mediated degradation","volume":"276","author":"Torres","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"36","key":"10.1016\/j.bcp.2019.113715_b0210","doi-asserted-by":"crossref","first-page":"26562","DOI":"10.1074\/jbc.M605391200","article-title":"PCAF modulates PTEN activity","volume":"281","author":"Okumura","year":"2006","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.bcp.2019.113715_b0215","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.cell.2006.11.039","article-title":"NEDD4-1 is a proto-oncogenic ubiquitin ligase for PTEN","volume":"128","author":"Wang","year":"2007","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.bcp.2019.113715_b0220","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1101\/gad.251785.114","article-title":"Poly-ADP ribosylation of PTEN by tankyrases promotes PTEN degradation and tumor growth","volume":"29","author":"Li","year":"2015","journal-title":"Genes Dev."},{"issue":"7264","key":"10.1016\/j.bcp.2019.113715_b0225","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1038\/nature08356","article-title":"Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling","volume":"461","author":"Huang","year":"2009","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.bcp.2019.113715_b0230","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/aji.12423","article-title":"Regulatory effect of catalpol on Th1\/Th2 cells in mice with bone loss induced by estrogen deficiency","volume":"74","author":"Lai","year":"2015","journal-title":"Am. J. Reprod. Immunol."},{"issue":"18","key":"10.1016\/j.bcp.2019.113715_b0235","doi-asserted-by":"crossref","DOI":"10.3390\/molecules24183302","article-title":"Catalpol in diabetes and its complications: a review of pharmacology, pharmacokinetics, and safety","volume":"24","author":"Bai","year":"2019","journal-title":"Molecules"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295219304149?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295219304149?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T13:12:03Z","timestamp":1757769123000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295219304149"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":47,"alternative-id":["S0006295219304149"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2019.113715","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Catalpol suppresses osteoclastogenesis and attenuates osteoclast-derived bone resorption by modulating PTEN activity","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2019.113715","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"113715"}}